{
    "code": "60000958",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000958",
    "time": "2022-09-30 06:07:36",
    "許可證字號": "衛部菌疫輸字第000958號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/08\/18",
    "發證日期": "103\/08\/18",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000095807",
    "中文品名": "益伏注射劑 5毫克\/毫升",
    "英文品名": "YERVOY (ipilimumab) Injection 5mg\/mL",
    "適應症": "1.無法切除或轉移性黑色素瘤：\r\n(1)適用於治療成人和 12 歲以上小兒之無法切除或轉移性黑色素瘤。\r\n(2)併用 nivolumab 適用於治療無法切除或轉移性黑色素瘤成人病人。\r\n2.晚期腎細胞癌：併用 nivolumab 適用於中度\/重度風險 (intermediate \/poor risk) 晚期腎細胞癌 (RCC) 病人的第一線治療。\r\n3.高度微衛星不穩定性(MSI-H)或錯配修復缺陷(dMMR)的轉移性大腸直腸癌：併用nivolumab適用於接受fluoropyrimidine、oxaliplatin和irinotecan治療後疾病惡化之具有高度微衛星不穩定性(MSI-H)或錯配修復缺陷(dMMR)的轉移性大腸直腸癌(CRC)成人病人。\r\n4.肝細胞癌：併用 nivolumab 適用於治療先前曾接受sorafenib治療的肝細胞癌 (HCC) 病人。\r\n5.轉移性或復發性非小細胞肺癌：\r\n(1)併用 nivolumab 適用於帶有PD-L1(≧1%)且不具EGFR或ALK腫瘤基因異常的成年轉移性或復發性非小細胞肺癌(NSCLC)病人的第一線治療。\r\n(2)併用 nivolumab 及2個週期含鉑化學治療適用於不具EGFR或ALK腫瘤基因異常的成年轉移性或復發性非小細胞肺癌(NSCLC)病人的第一線治療。\r\n6.惡性肋膜間皮瘤：併用 nivolumab 適用於無法切除之惡性肋膜間皮瘤成人病人的第一線治療。\r\n7.食道癌：併用 nivolumab 適用於晚期或轉移性食道鱗狀細胞癌 (ESCC) 病人的第一線治療。",
    "劑型": "27D注射液劑",
    "包裝": "100支以下盒裝 10毫升小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "108\/08\/18",
    "主成分略述": "Ipilimumab",
    "限制項目": "1D須執行風險管理計畫",
    "申請商名稱": "1404501100  台灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0021000  BRISTOL-MYERS SQUIBB HOLDINGS PHARMA LTD.",
            "製造廠廠址": "BO TIERRAS NUEVAS,ROUTE 686,KM 2.3,MANATI,PUERTO RICO 00674,U.S.A.",
            "製造廠公司地址": "ROUTE 206 AND PROVINCE LINE ROAD,PRINCETON,NEW JERSEY 08543,U.S.A.",
            "製造廠國別": "PUERTO RICO",
            "製程": "成品及包裝廠"
        },
        {
            "製造廠名稱": "FUS0485000  BAXTER PHARMACEUTICAL SOLUTIONS LLC",
            "製造廠廠址": "927 SOUTH CURRY PIKE, BLOOMINGTON, INDIANA 47403, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIT0287100  BRISTOL-MYERS SQUIBB S.R.L.",
            "製造廠廠址": "LOCALIT&#39;A FONTANA DEL CERASO 03012 ANAGNI ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FKR0186000  Samsung Biologics Co. Ltd.",
            "製造廠廠址": "300 Songdo bio-daero, Yeonsu-gu, Incheon City, Korea 21987, Korea Republic",
            "製造廠公司地址": "",
            "製造廠國別": "KOREA",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0037100  Bristol-Myers Squibb Company",
            "製造廠廠址": "6000 Thompson Road, East Syracuse, New York 13057, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013004100",
            "成分名稱": "Ipilimumab",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "1支注射劑\/ 一盒",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛部菌疫輸字第000958號 益伏注射劑 5毫克毫升 藥品外觀-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000958&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "YERVOY中文仿單 EC 648+30min infusion cln_Final (002)-111-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000958&Seq=011&Type=9"
        },
        {
            "title": "益伏注射劑標籤-109-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000958&Seq=014&Type=8"
        },
        {
            "title": "益伏注射劑外盒-109-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000958&Seq=013&Type=8"
        }
    ]
}